argenx SE reported 33.59 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
AstraZeneca 20.04 12.31 Jun/2025
Galapagos 53.92 0 Mar/2025
Genmab 12.13 1.06 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
GRIFOLS 45 27.14 Jun/2025
Hikma Pharmaceutical 19.56 8.4 Jun/2024
Qiagen NV 24.01 79.75 Jun/2025
UCB 156.24 77.45 Jun/2024